Novel 660 300 mg (Trimethobenzamide hydrochloride 300 mg)

Pill imprint Novel 660 300 mg has been identified as Trimethobenzamide hydrochloride 300 mg.

Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for Novel 660 300 mg (Trimethobenzamide hydrochloride 300 mg)

Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride
Imprint:
Novel 660
300 mg
Strength:
300 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gavis Pharmaceuticals
National Drug Code (NDC):
43386-0660
Inactive Ingredients:
lactose monohydrate
magnesium stearate
corn starch
D&C Red No. 28
gelatin
FD&C Blue No. 1
FD&C Red No. 40
titanium dioxide
soya lecithin
water
shellac
ethylene glycol monoethyl ether

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)